Question 1

What is Denali Therapeutics?

Accepted Answer

Denali Therapeutics is a Company.

Question 2

How often does Denali Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Denali Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 03, 2026.

Question 4

When was Denali Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 18, 2026.

Question 5

What is Denali Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Denali Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Denali Therapeutics?

Accepted Answer

Takeda Terminates DNL593 Collaboration with Denali (Apr 03, 2026, 7 articles).

Question 8

How did the "Takeda Terminates DNL593 Collaboration with Denali" event impact Denali Therapeutics?

Accepted Answer

Denali Therapeutics regained full rights to DNL593 after Takeda terminated their collaboration, allowing Denali Therapeutics to independently advance the therapy for FTD-GRN.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.